Literature DB >> 15793096

Modafinil in sports: ethical considerations.

K R Kaufman1.   

Abstract

Performance enhancing agents are prohibited in athletic competition so that only athletic skills can determine outcomes. Modafinil is a novel non-addicting psychostimulant approved for treatment of narcolepsy. Does its use, especially for medical indications, violate the Olympic Movement Anti-Doping Code? This is discussed with reference to a current high profile case.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Substances:

Year:  2005        PMID: 15793096      PMCID: PMC1725194          DOI: 10.1136/bjsm.2004.016303

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  40 in total

Review 1.  Glutamatergic agents for cocaine dependence.

Authors:  Charles Dackis; Charles O'Brien
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

2.  Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy.

Authors: 
Journal:  Sleep Med       Date:  2000-07-01       Impact factor: 3.492

3.  The toxic torch of the modern Olympic Games.

Authors:  Heather M Prendergast; Todd Bannen; Timothy B Erickson; Kierre R Honore
Journal:  Vet Hum Toxicol       Date:  2003-03

4.  An evaluation of the abuse potential of modafinil using methylphenidate as a reference.

Authors:  D R Jasinski
Journal:  J Psychopharmacol       Date:  2000-03       Impact factor: 4.153

5.  Efficacy and safety of modafinil for improving daytime wakefulness in patients treated previously with psychostimulants.

Authors:  Jonathan R L Schwartz; Neil T Feldman; June M Fry; John Harsh
Journal:  Sleep Med       Date:  2003-01       Impact factor: 3.492

6.  Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity.

Authors:  Angela P Makris; Craig R Rush; Robert C Frederich; Thomas H Kelly
Journal:  Appetite       Date:  2004-04       Impact factor: 3.868

7.  Orexin (hypocretin)/dynorphin neurons control GABAergic inputs to tuberomammillary neurons.

Authors:  Krister S Eriksson; Olga A Sergeeva; Oliver Selbach; Helmut L Haas
Journal:  Eur J Neurosci       Date:  2004-03       Impact factor: 3.386

Review 8.  Clinical aspects and pathophysiology of narcolepsy.

Authors:  Yves Dauvilliers; Michel Billiard; Jacques Montplaisir
Journal:  Clin Neurophysiol       Date:  2003-11       Impact factor: 3.708

9.  Modafinil in children with attention-deficit hyperactivity disorder.

Authors:  Thomas A Rugino; Teresa C Samsock
Journal:  Pediatr Neurol       Date:  2003-08       Impact factor: 3.372

10.  Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy.

Authors:  Philip M Becker; Jonathan R L Schwartz; Neil T Feldman; Rod J Hughes
Journal:  Psychopharmacology (Berl)       Date:  2003-11-25       Impact factor: 4.530

View more
  1 in total

Review 1.  Anabolic steroid use: patterns of use and detection of doping.

Authors:  Michael R Graham; Bruce Davies; Fergal M Grace; Andrew Kicman; Julien S Baker
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.